NASDAQ: PRE - Prenetics Global Limited

六个月盈利: -1.83%
股息率: 0.00%
部门: Healthcare

促销时间表 Prenetics Global Limited


关于公司 Prenetics Global Limited

Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use.

更多详情
The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; ACTOnco, a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+, a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung, a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion, a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra, a genomic profiling service for solid tumors. It also offers ACTMonitor, a test that analyzes 50 forms of circulating tumor DNA in the bloodstream; and ACT Risk, a screening of 67 cancer genes associated with 9 common hereditary cancers and 11 cancer syndromes. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

IPO date 2022-05-18
ISIN KYG722451062
Industry Insurance
Sector Financials
Валюта usd
Валюта отчета usd
Сайт https://www.prenetics.com
Цена ао 3.56
每日价格变化: -1.49% (5.79)
每周价格变化: +1.04% (5.645)
每月价格变化: +28.75% (4.43)
3个月内价格变化: +38.61% (4.115)
六个月内的价格变化: -1.83% (5.81)
每年价格变化: -3.49% (5.91)
3年内价格变化: -42.33% (9.89)
5年内价格变化: 0% (5.7038)
10年价格变化: 0% (5.7038)
年初以来价格变化: +26.75% (4.5)

低估

姓名 意义 年级
P/S 2.83 6
P/BV 0.2927 10
P/E 0 0
EV/EBITDA -0.4065 0
全部的: 5.75

效率

姓名 意义 年级
ROA, % -24.68 0
ROE, % -30.4 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 1.35

责任

姓名 意义 年级
Debt/EBITDA -0.053 10
全部的: 9.8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 136.33 10
盈利能力 Ebitda, % 158.9 10
盈利能力 EPS, % 2964.52 10
全部的: 10

ETF 分享, % 本年盈利能力, % 股息, %
Vanguard Intermediate-Term Corporate Bond ETF 0.02 0.1996 4.17
Vanguard Intermediate-Term Bond ETF 0.01 -1.1 3.45
Schwab U.S. Aggregate Bond ETF 0 -1.22 3.65



导师 职称 支付 出生年份
Mr. Hoi Chun Lo Chief Financial Officer N/A 1985 (40 年)
Dr. Yung Ho Wong DPHIL Chief Technology Officer N/A 1982 (43 年)
Ms. Samantha Kwok Chief of Staff to Group CEO & Vice President of People & Operations N/A
Dr. Senthil Sundaram M.D. Chief Clinical Officer N/A 1974 (51 年)
Mr. Joel Neoh Chief Consumer Officer & CEO for CircleDNA N/A 1984 (41 年)
Mr. Sheng Wu Yeung Co-Founder, Chairperson & CEO N/A 1979 (46 年)
Dr. Chi Hung Tzang Ph.D. Co-Founder & Chief Scientific Officer N/A 1974 (51 年)
Mr. Walt Ling Chief Executive Officer of ACT Genomics N/A

地址: Hong Kong, Quarry Bay, Unit 701-706. K11 Atelier King’s Road - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.prenetics.com